BioVoice News September 2016 Issue 5 Volume 1 | Page 27

How do you look at the concerns of the MedTech MNCs when they say that they are being penalized for being not being indigenous despite the fact that they could contribute in Make in India? Pray how are they being penalized till date? There have virtually nil or negligible tariff barriers which are usually there in every developing country of some reasonable level to allow domestic manufacturing to be viable. There are virtually no non-tariff barriers which even developed economies use to protect their domestic industry and raise the bar to access markets. 100 percent FDI in med